Mobile applications for anxiety and stress reduction: potential for preventing noncommunicable diseases
https://doi.org/10.15829/1560-4071-2021-4681
Abstract
The article discusses using mobile applications for smartphones as tools to reduce anxiety and stress. The modern views on pathogenesis of the relationship between stress, anxiety disorders and cardiovascular disease are considered. Based on a review of some representative studies, a methodology for evaluating the characteristics and functions of mobile applications for managing anxiety and stress symptoms is proposed. The applications selected for analysis were tested according to this methodology. There are following key features of the Russianlanguage field of mobile applications for anxiety and stress reduction: a small number of applications, high prevalence of using breathing exercises, meditations and sound therapy, an extremely low disease specificity and focus mainly on helping with general symptoms of anxiety.
About the Authors
K. A. Zamyatin
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
D. I. Nozdrachev
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
M. N. Solovieva
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
References
1. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC), European Heart Journal, 2021;34(42):3227- 37. doi:10.1093/eurheartj/ehab484.
2. Psychiatry: National Guidelines. Aleksandrovskii YuA, Neznanov NG (eds.). 2nd ed., rev. and exp. Moscow: GEOTAR-Media, 2020. p. 1008. (In Russ.) ISBN: 978-5-9704-5414-5.
3. Drissi N, Ouhbi S, Idrissi MAJ, Ghogho M. An analysis on self-management and treatment-related functionality and characteristics of highly rated anxiety apps. Int J Med Inform. 2020;141(9):104243. doi:10.1016/j.ijmedinf.2020.104243.
4. Purves KL, Coleman JRI, Meier SM, et al. A major role for common genetic variation in anxiety disorders. Mol Psychiatry. 2020;25(12):3292-303. doi:10.1038/s41380-019-0559-1.
5. Juruena MF, Eror F, Cleare AJ, Young AH. The Role of Early Life Stress in HPA Axis and Anxiety. Adv Exp Med Biol. 2020;1191:141-53. doi:10.1007/978-981-32-9705-0_9.
6. Agorastos A, Chrousos GP. The neuroendocrinology of stress: the stress-related continuum of chronic disease development. Mol Psychiatry. 2021. doi:10.1038/s41380-021-01224-9. Online ahead of print.
7. Nozdrachev DI, Zamyatin KA, Taratukhin EO. Digital tools for improving medication adherence. Russian Journal of Cardiology. 2019;(12):96-102. (In Russ.) doi:10.15829/1560-4071-2019-12-96-102.
8. Sucala M, Cuijpers P, Muench F, et al. Anxiety: There is an app for that. A systematic review of anxiety apps. Depress Anxiety. 2017;34(6):518-25. doi:10.1002/da.22654.
9. Alyami M, Giri B, Alyami H, Sundram F. Social anxiety apps: a systematic review and assessment of app descriptors across mobile store platforms. Evid Based Ment Health. 2017;20(3):65-70. doi:10.1136/eb-2017-102664.
10. Firth J, Torous J, Carney R, et al. Digital Technologies in the Treatment of Anxiety: Recent Innovations and Future Directions. Curr Psychiatry Rep. 2018;20(6):44. doi:10.1007/s11920-018-0910-2.
11. Huckvale K, Nicholas J, Torous J, Larsen ME. Smartphone apps for the treatment of mental health conditions: status and considerations. Curr Opin Psychol. 2020;36(12):65- 70. doi:10.1016/j.copsyc.2020.04.008.
12. Marshall JM, Dunstan DA, Bartik W. Apps With Maps-Anxiety and Depression Mobile Apps With Evidence-Based Frameworks: Systematic Search of Major App Stores. JMIR Ment Health. 2020;7(6):e16525. doi:10.2196/16525.
13. Taratukhin EO, Kudinova MA, Shaydyuk ОYu, et al. Person-centered interview as a tool for clinical work in myocardial infarction setting. Cardiovascular Therapy and Prevention. 2017;16(1):34-9. (In Russ.) doi:10.15829/1728-8800-2017-1-34-39.
14. Semiokhina AS, Taratukhin EO, Bayandin NL, et al. Life quality in one year after myocardial infraction with incomplete revascularization. Russian Journal of Cardiology. 2017;(1):102-5. (In Russ.) doi:10.15829/1560-4071-2017-1-102-105.
Supplementary files
Review
For citations:
Zamyatin K.A., Nozdrachev D.I., Solovieva M.N. Mobile applications for anxiety and stress reduction: potential for preventing noncommunicable diseases. Russian Journal of Cardiology. 2021;26(9):4681. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4681
Views:
715
Email this article 